MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Subclinical inflammation and Parkinson’s disease

    G. Pagano (Basel, Switzerland)

    Objective: To investigate subclinical inflammation in individuals with early drug-naive Parkinson’s disease (PD). Background: Neutrophil-to-lymphocyte ratio (NLR) is used as a marker of subclinical inflammation.…
  • MDS Virtual Congress 2021

    Apathy: an underestimated feature in premotor period of GBA and LRRK2 non-manifesting mutation carriers.

    I. Pachi, C. Koros, A. Simitsi, D. Papadimitriou, A. Bougea, A. Prentakis, N. Papagiannakis, M. Bozi, R. Antonelou, E. Angelopoulou, I. Beratis, M. Stamelou, X. Trapali, S. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: The aim was to detect the differences between GBA and LRRK2 mutation carriers without Parkinson’s disease and healthy controls (HC) on neuropsychiatric symptoms. Background:…
  • MDS Virtual Congress 2021

    Genetic hypokinetic rigid syndrome: Clinical phenotypes from infancy to adolescence in a series of Chilean Patients

    D. Munoz, M. Troncoso, V. Naranjo, P. Santander, S. Lara, V. Saez, M. Hidalgo, I. Ruiz (Santiago, Chile)

    Objective: The aim of this study is to characterize child population with genetic early-onset parkinsonism. Background: Early forms of Parkinsonism have many distinctive features as…
  • MDS Virtual Congress 2021

    Atypical hemifacial spasm caused by an epidermoid cyst of the cerebellopontine angle

    J. Rosa, S. Dias, M. Dias (Lisbon, Portugal)

    Objective: To describe a case of secondary hemifacial spasm with atypical features. Background: Hemifacial spasm (HS) is a peripherally induced movement disorder involving involuntary unilateral…
  • MDS Virtual Congress 2021

    Motor-cognitive interference during touchscreen manipulations in Parkinson’s disease

    J. de Vleeschhauwer, S. Broeder, P. Ginis, L. Janssens, A. Nieuwboer, E. Nackaerts (Leuven, Belgium)

    Objective: To examine the effects of adding a secondary cognitive task to performing motor tasks on a touchscreen in Parkinson’s disease (PD) and healthy controls…
  • MDS Virtual Congress 2021

    SPEECH BIOMARKERS IN HEREDITARY SPASTIC PARAPLEGIA

    M. Olchik, L. Scudeiro, V. Dos Santos, A. Ayres, R. Rech, D. Burguêz, G. Machado, C. González-Salazar, M. Padovani, M. França Junior, J. Saute (Porto Alegre, Brazil)

    Objective: To evaluate the frequency and clinical characterization of dysarthria in different types of HSP. Background: Hereditary spastic paraplegias (HSP) are a group of genetic…
  • MDS Virtual Congress 2021

    Validity and Reliability of Timed Get-Up and Go Test and Unified Parkinson’s disease Rating Scales on Parkinson ’s disease

    T. T (Bangalore, India)

    Objective: This study is an attempt to find the inter-rater and intra-rater reliability of both timed up and go test and unified Parkinson’s rating scale.…
  • MDS Virtual Congress 2021

    Attitudes towards risk disclosure in prodromal Parkinson’s disease. Is there a cultural difference?

    G. Kayis, R. Yilmaz, G. Yalcin-Cakmakli, B. Arda, B. Elibol, MC. Akbostanci (Ankara, Turkey)

    Objective: To investigate the attitudes of individuals with and without Parkinson’s disease (IwPD, IwoPD) relevant to risk disclosure for future PD in Turkish culture. Background:…
  • MDS Virtual Congress 2021

    D-penicillamine induced lupus erythematosus – the complication of Wilson’s disease treatment – a case report.

    A. Antos, T. Litwin, A. Przybyłkowski, M. Skowrońska, I. Kurkowska-Jastrzębska, A. Członkowska (Warsaw, Poland)

    Objective: Wilson’s disease (WD) is an inherited disorder of copper metabolism with copper accumulation in different organs and clinical symptoms related to the affected organs…
  • MDS Virtual Congress 2021

    The Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD): a new tool to assess gastrointestinal dysfunction in Parkinson’s Disease

    M. Camacho, J. Greenland, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: Objective: To develop and validate the Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD), a self-report scale designed to assess presence and severity of Gastrointestinal…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley